BlinkLab is trading 10.43% up now at $0.90, with the rise appearing primarily supported by broader healthcare-sector strength and investor rotation; no company-specific announcement has been identified for August 20, 2026.
- Latest material update remains the August 5 European ADHD study, reporting 82% sensitivity and 83% specificity in 208 children, predating today’s move.
- Recent volatility saw the stock advance from A$0.67 on August 17 to A$0.85 on August 18, before closing at A$0.81 on August 19.